Hospital Universitari Vall d'Hebron; Servicio de Neumo-Inmunologia

Barcelona 08035

0 studies enrolling now · 2 studies all time

What they study most

Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Relapsing-Remitting

Studies at this site

• A Study of the Efficacy and Safety of Ocrelizumab in Patients With Relapsing-Remitting Multiple Sclerosis — Completed
• A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis — Completed